Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Nov 8, 2024. (Total: 233355Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 7 (of 7 Records)

Query Trace: DNA Damage and NFE2L2[original query]
Genetic variants involved in oxidative stress, base excision repair, DNA methylation, and folate metabolism pathways influence myeloid neoplasias susceptibility and prognosis.
Molecular carcinogenesis 2016 Mar .
Gonçalves Ana Cristina, Alves Raquel, Baldeiras Inês, Cortesão Emília, Carda José Pedro, Branco Claudia C, Oliveiros Bárbara, Loureiro Luísa, Pereira Amélia, Nascimento Costa José Manuel, Sarmento-Ribeiro Ana Bela, Mota-Vieira Lui
Genetic Variants in CD44 and MAT1A Confer Susceptibility to Acute Skin Reaction in Breast Cancer Patients Undergoing Radiation Therapy.
International journal of radiation oncology, biology, physics 2016 Sep .
Mumbrekar Kamalesh Dattaram, Bola Sadashiva Satish Rao, Kabekkodu Shama Prasada, Fernandes Donald Jerard, Vadhiraja Bejadi Manjunath, Suga Tomo, Shoji Yoshimi, Nakayama Fumiaki, Imai Takashi, Satyamoorthy Kapaet
Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung Adenocarcinoma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2019 7 14 (11): 1924-1934.
Goeman Frauke, De Nicola Francesca, Scalera Stefano, Sperati Francesca, Gallo Enzo, Ciuffreda Ludovica, Pallocca Matteo, Pizzuti Laura, Krasniqi Eriseld, Barchiesi Giacomo, Vici Patrizia, Barba Maddalena, Buglioni Simonetta, Casini Beatrice, Visca Paolo, Pescarmona Edoardo, Mazzotta Marco, De Maria Ruggero, Fanciulli Maurizio, Ciliberto Gennaro, Maugeri-Saccà Marcel
KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition.
Cancer discovery 2020 Oct .
Binkley Michael S, Jeon Young-Jun, Nesselbush Monica, Moding Everett J, Nabet Barzin Y, Almanza Diego, Kunder Christian, Stehr Henning, Yoo Christopher H, Rhee Siyeon, Xiang Michael, Chabon Jacob J, Hamilton Emily, Kurtz David M, Gojenola Linda, Owen Susie Grant, Ko Ryan B, Shin June Ho, Maxim Peter G, Lui Natalie S, Backhus Leah M, Berry Mark F, Shrager Joseph B, Ramchandran Kavitha J, Padda Sukhmani K, Das Millie, Neal Joel W, Wakelee Heather A, Alizadeh Ash A, Loo Billy W, Diehn Maximili
KEAP1/NFE2L2 Mutations of Liquid Biopsy as Prognostic Biomarkers in Patients With Advanced Non-Small Cell Lung Cancer: Results From Two Multicenter, Randomized Clinical Trials.
Frontiers in oncology 2021 11 659200.
Zhu Hongyuan, Xie Daipeng, Yu Yunfang, Yao Lintong, Xu Bin, Huang Luyu, Wu Shaowei, Li Fasheng, Zheng Yating, Liu Xinyi, Xie Wenzhuan, Huang Mengli, Li Hao, Zheng Shaopeng, Zhang Dongkun, Qiao Guibin, Chan Lawrence W C, Zhou Hai
Decreased DNA repair capacity caused by exposure to metal mixtures is modulated by the PARP1 rs1136410 variant in newborns from a polluted metropolitan area.
Environmental research 2023 11 241 117631.
Marvin Paz-Sabillón, Nereida Montes-Castro, Luisa Torres-Sánchez, Luz M Del Razo, Emilio J Córdova, Betzabet Quintanilla-Ve
Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patents with Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Durvalumab.
JAMA network open 2023 1 6 (1): e2249591.
Lebow Emily S, Shepherd Annemarie, Eichholz Jordan E, Offin Michael, Gelblum Daphna Y, Wu Abraham J, Simone Charles B, Schoenfeld Adam J, Jones David R, Rimner Andreas, Chaft Jamie E, Riaz Nadeem, Gomez Daniel R, Shaverdian Nar
TOP